Evidence map›Paper›PMID 37703949›Full record

ArticleExperimental neurology2023

Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.

Qi Zhang, Cynthia Forster-Gibson, Eduard Bercovici, Alexandra Bernardo, Fei Ding, Wangzhen Shen, Katherine Langer, Tonia Rex, Jing-Qiong Kang

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Qi ZhangDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America; Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Department of Neurology, Nantong University, 19 Qixiu Road, Nantong, JS 226001, PR China.
Cynthia Forster-GibsonLaboratory Medicine and Genetics, Trillium Health Partners, Mississauga and Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Canada.
Eduard BercoviciDivision of Neurology, Faculty of Medicine, University of Toronto, Canada.
Alexandra BernardoDepartment of Ophthalmology & Visual Sciences Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America.
Fei DingKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Department of Neurology, Nantong University, 19 Qixiu Road, Nantong, JS 226001, PR China.
Wangzhen ShenDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America.
Katherine LangerDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America.
Tonia RexDepartment of Ophthalmology & Visual Sciences Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America.
Jing-Qiong KangDepartment of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, United States of America; Department of Pharmacology, Vanderbilt University, United States of America; Vanderbilt Brain Institute and Vanderbilt Kennedy Center of Human Development, Vanderbilt University, Nashville, TN 37212, United States of America. Electronic address: jingqiong.kang@vanderbilt.edu.
Nantong University · CNVanderbilt Health · USVanderbilt University Medical Center · USTrillium Health Centre · CAUniversity of Toronto · CAVanderbilt University · US

Funding

Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic NeuropathyU24EY029893 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BARANOV, PETR, REX, TONIA S · 2018 to 2022
$7.2M
Role of the Nrf2/ARE pathway in retinal ganglion cells during glaucoma pathogenesis and neuroprotectionR01EY022349 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CALKINS, DAVID J., REX, TONIA S · 2012 to 2021
$3.8M
Promoting Protein Trafficking with 4-phenylbutyrate to Treat Genetic EpilepsyR01NS121718 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jing-Qiong Kang · 2022 to 2026
$2.2M
Altered synapse formation and function in a novel Dravet syndrome mouse modelR01NS082635 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KANG, JING-QIONG · 2013 to 2017
$1.7M
NEI NIH HHS P30 EY008126NEI NIH HHS R01 EY022349NEI NIH HHS U24 EY029893NICHD NIH HHS P50 HD103537NINDS NIH HHS R01 NS082635NINDS NIH HHS R01 NS121718
6 · The paper itself

Abstract

objectiveGABA

methodsElectroencephalography was conducted in both human and mice with the same gene loss. GABA

resultsThe patient has bilateral optical nerve atrophy. Mice displayed spontaneous seizures, reduced electroretinography oscillatory potential and reduced GABA

conclusionsThis study is the first report of haploinsufficiency of two GABR epilepsy genes and visual impairment due to altered axonal myelination and resultant optic nerve atrophy. The study suggests the far-reaching impact of GABR mutations and the translational significance of animal models with the same etiology.

Indexed as

EpilepsyReceptors, GABA-AAnimalsAtrophyBlindnessDisease Models, AnimalEvoked Potentials, VisualHumansMicePhenobarbitalGABRA1 protein, humanGABRG2 protein, humanPhenobarbitalReceptors, GABA-ABlindnessCopy number variation (CNV)Electroencephalography (EEG)Electroretinography (ERG)EpilepsyGABA(A) receptorsOptic nerve atrophy

Identifiers

PMID37703949
PMCPMC10591898
OpenAlexW4386615012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.